Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biologically active hemagglutinin from type a Clostridium botulinum and methods of use

Biologically active hemagglutinin from type a Clostridium botulinum and methods of use

US Patent 9139624 · Granted Sep 22, 2015

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Complex of botulinum neurotoxin E and its binding protein as a formulation with 2025
Transportation route error detection and adjustment2025
Dynamically adjusting a pool of transportation provider devices in a prioritized2025
Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vac2025
Dynamically adjusting transportation provider pool size2025
Tetanus vaccine platform for embedding COVID-19 vaccine2025
Complex of botulinum neurotoxin E and its binding protein as a formulation with 2024
Transportation route error detection and adjustment2023
Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vac2023
Dynamically adjusting transportation provider pool size2023
Dynamically adjusting transportation provider pool size2023
Pharmaceutical composition for treating cancer2022